Stock Earnings

Question 1

¿Cuáles son los estados financieros clave de Hansa Biopharma AB?

Accepted Answer

Según el último estado financiero (Form-10K), Hansa Biopharma AB tiene un total de activos de $800, una ganancia neta loss de $-807

Question 2

¿Cuáles son los ratios financieros clave para HNSBF?

Accepted Answer

El ratio corriente de Hansa Biopharma AB es 0.57, el margen neto es -471.92, las ventas por acción son $2.72.

Question 3

¿Cómo se desglosan los ingresos de Hansa Biopharma AB por segmento o geografía?

Accepted Answer

Hansa Biopharma AB largest revenue segment is Antibody-cleaving Enzyme Technology Platform, at a revenue of 171,316,000 in the most earnings release.For geography, Europe is the primary market for Hansa Biopharma AB, at a revenue of 140,237,000.

Question 4

¿Es rentable Hansa Biopharma AB?

Accepted Answer

no, según los últimos estados financieros, Hansa Biopharma AB tiene una ganancia neta loss de $-807

Question 5

¿Tiene Hansa Biopharma AB alguna deuda?

Accepted Answer

yes, Hansa Biopharma AB tiene una deuda de 1,390

Question 6

¿Cuántas acciones en circulación tiene Hansa Biopharma AB?

Accepted Answer

Hansa Biopharma AB tiene un total de acciones en circulación de 67.81

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	178	171	134	154	33	6
Revenue Growth (YoY)	-6%	28%	-13%	367%	450%	100%
Cost of Revenue	72	83	63	38	15	0
Gross Profit	106	87	70	116	18	5
Selling, General & Admin	323	342	448	334	324	202
Research & Development	328	367	402	339	225	227
Operating Expenses	652	731	862	692	558	427
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-636	-804	-830	-609	-548	-420
Income Tax Expense	4	3	0	1	0	0
Net Income	-641	-807	-831	-611	-548	-420
Net Income Growth	-2%	-3%	36%	12%	30%	17%
Shares Outstanding (Diluted)	84.76	62.83	52.54	44.92	44.47	42.17
Shares Change (YoY)	25%	20%	17%	1%	5%	5%
EPS (Diluted)	-7.56	-12.84	-15.83	-13.6	-12.32	-9.97
EPS Growth	-22%	-19%	16%	10%	24%	11%
Free Cash Flow	-501	-675	-755	-506	-483	-290
Free Cash Flow Per Share	-5.91	-10.74	-14.36	-11.26	-10.86	-6.87
Gross Margin	59.55%	50.87%	52.23%	75.32%	54.54%	83.33%
Operating Margin	-306.17%	-376.6%	-590.29%	-374.02%	-1,633.33%	-7,033.33%
Profit Margin	-360.11%	-471.92%	-620.14%	-396.75%	-1,660.6%	-7,000%
Free Cash Flow Margin	-281.46%	-394.73%	-563.43%	-328.57%	-1,463.63%	-4,833.33%
EBITDA	--	-616	-772	-564	-531	-415
EBITDA Margin	--	-360.23%	-576.11%	-366.23%	-1,609.09%	-6,916.66%
D&A For EBITDA	--	28	19	12	8	7
EBIT	-545	-644	-791	-576	-539	-422
EBIT Margin	-306.17%	-376.6%	-590.29%	-374.02%	-1,633.33%	-7,033.33%
Effective Tax Rate	-0.62%	-0.37%	0%	-0.16%	0%	0%

Hansa Biopharma AB (HNSBF) Price

HNSBF Stock Price Chart

HNSBF Income

Follow-Up Questions